Lingohr Asset Management GmbH Has $308,000 Position in Docusign Inc. $DOCU

Key Points

• Lingohr Asset Management GmbH significantly reduced its stake in Docusign Inc. by 95.3% in Q2, now holding only 3,955 shares valued at $308,000.
• Institutional investors own a substantial 77.64% of Docusign's stock, with various firms, including Hedges Asset Management LLC and Voya Investment Management LLC, making notable transactions in the company.
• Docusign's most recent quarterly earnings exceeded expectations, reporting $800.64 million in revenue and an EPS of $0.92 for the quarter, beating analyst predictions.

Lingohr Asset Management GmbH trimmed its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 95.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,955 shares of the company's stock after selling 80,706 shares during the quarter. Lingohr Asset Management GmbH's holdings in Docusign were worth $308,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Hemington Wealth Management raised its holdings in Docusign by 318.1% during the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock worth $28,000 after purchasing an additional 264 shares in the last quarter. Banque Transatlantique SA bought a new stake in shares of Docusign in the 1st quarter worth $26,000. Golden State Wealth Management LLC raised its stake in shares of Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after buying an additional 322 shares in the last quarter. Summit Securities Group LLC bought a new stake in Docusign in the first quarter worth about $34,000. Finally, Wood Tarver Financial Group LLC bought a new stake in Docusign in the fourth quarter worth about $37,000. Institutional investors own 77.64% of the company's stock.

Insider Buying and Selling at Docusign

In other Docusign news, Director Anna Marrs sold 728 shares of the stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $80.30, for a total transaction of $58,458.40. Following the transaction, the director owned 10,799 shares in the company, valued at $867,159.70. This trade represents a 6.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Peter Solvik sold 15,000 shares of the stock in a transaction that occurred on Monday, September 15th. The shares were sold at an average price of $81.48, for a total value of $1,222,200.00. Following the transaction, the director owned 135,253 shares in the company, valued at approximately $11,020,414.44. This trade represents a 9.98% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 82,533 shares of company stock worth $6,598,028 in the last 90 days. Company insiders own 1.01% of the company's stock.

Docusign Stock Down 0.6%

Shares of DOCU traded down $0.50 during mid-day trading on Friday, hitting $84.52. 921,896 shares of the company's stock were exchanged, compared to its average volume of 2,680,333. The firm has a fifty day moving average of $76.17 and a two-hundred day moving average of $79.28. Docusign Inc. has a twelve month low of $57.58 and a twelve month high of $107.86. The stock has a market cap of $17.00 billion, a price-to-earnings ratio of 63.50, a P/E/G ratio of 4.43 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.84 by $0.08. The company had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. Docusign's quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, equities analysts predict that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign declared that its board has initiated a share repurchase plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 6.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

DOCU has been the topic of a number of research reports. Wall Street Zen upgraded shares of Docusign from a "hold" rating to a "buy" rating in a report on Saturday, September 13th. Evercore ISI boosted their target price on shares of Docusign from $90.00 to $92.00 and gave the stock an "in-line" rating in a report on Friday, September 5th. UBS Group set a $95.00 price target on Docusign in a report on Friday, September 5th. JPMorgan Chase & Co. upped their price target on Docusign from $77.00 to $80.00 and gave the company a "neutral" rating in a report on Friday, September 5th. Finally, Citigroup boosted their target price on Docusign from $110.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, September 4th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $94.14.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.